Tumor-Naïve & Blood-Informed MRD Solutions for Global Oncology Drug Development

• Tumor-naïve, methylation-based MRD solutions for broad clinical applications
• Personalized, baseline-informed MRD solutions leveraging baseline tissue, blood, or urine samples
• Harmonized tissue and liquid biopsy testing solutions supporting global oncology clinical trials across the U.S. and China

Speakers:

Alexander Kuklin

Vice President, BioPharma Partnerships

Predicine